These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 26220979)
1. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease. Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979 [TBL] [Abstract][Full Text] [Related]
2. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY) intranasal delivery alleviates Machado-Joseph disease. Duarte-Neves J; Cavadas C; Pereira de Almeida L Sci Rep; 2021 Feb; 11(1):3345. PubMed ID: 33558582 [TBL] [Abstract][Full Text] [Related]
4. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease. Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739 [TBL] [Abstract][Full Text] [Related]
5. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684 [TBL] [Abstract][Full Text] [Related]
6. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease. Gonçalves N; Simões AT; Cunha RA; de Almeida LP Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556 [TBL] [Abstract][Full Text] [Related]
7. Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice. Mendonça LS; Nóbrega C; Hirai H; Kaspar BK; Pereira de Almeida L Brain; 2015 Feb; 138(Pt 2):320-35. PubMed ID: 25527827 [TBL] [Abstract][Full Text] [Related]
8. RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3. Nóbrega C; Codêsso JM; Mendonça L; Pereira de Almeida L Hum Gene Ther; 2019 Jul; 30(7):841-854. PubMed ID: 30760052 [TBL] [Abstract][Full Text] [Related]
9. ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease. Vasconcelos-Ferreira A; Martins IM; Lobo D; Pereira D; Lopes MM; Faro R; Lopes SM; Verbeek D; Schmidt T; Nóbrega C; Pereira de Almeida L Mol Ther; 2022 Jan; 30(1):370-387. PubMed ID: 34298131 [TBL] [Abstract][Full Text] [Related]
10. Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease. Simões AT; Gonçalves N; Nobre RJ; Duarte CB; Pereira de Almeida L Hum Mol Genet; 2014 Sep; 23(18):4932-44. PubMed ID: 24817574 [TBL] [Abstract][Full Text] [Related]
11. Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models. Mendonça LS; Nóbrega C; Tavino S; Brinkhaus M; Matos C; Tomé S; Moreira R; Henriques D; Kaspar BK; Pereira de Almeida L Hum Mol Genet; 2019 Nov; 28(22):3691-3703. PubMed ID: 31127937 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology. Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Conceição M; Déglon N; de Almeida LP Cerebellum; 2013 Aug; 12(4):441-55. PubMed ID: 23242710 [TBL] [Abstract][Full Text] [Related]
13. Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway. Cunha-Santos J; Duarte-Neves J; Carmona V; Guarente L; Pereira de Almeida L; Cavadas C Nat Commun; 2016 May; 7():11445. PubMed ID: 27165717 [TBL] [Abstract][Full Text] [Related]
14. Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease. Costa Mdo C; Luna-Cancalon K; Fischer S; Ashraf NS; Ouyang M; Dharia RM; Martin-Fishman L; Yang Y; Shakkottai VG; Davidson BL; Rodríguez-Lebrón E; Paulson HL Mol Ther; 2013 Oct; 21(10):1898-908. PubMed ID: 23765441 [TBL] [Abstract][Full Text] [Related]
17. RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease. Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Déglon N; de Almeida LP PLoS One; 2014; 9(8):e100086. PubMed ID: 25144231 [TBL] [Abstract][Full Text] [Related]
18. Protective roles of carbonic anhydrase 8 in Machado-Joseph Disease. Hsieh M; Hsieh BY; Ma CY; Li YT; Liu CS; Lo CM J Neurosci Res; 2019 Oct; 97(10):1278-1297. PubMed ID: 31157458 [TBL] [Abstract][Full Text] [Related]
19. Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia. Gonçalves N; Simões AT; Prediger RD; Hirai H; Cunha RA; Pereira de Almeida L Ann Neurol; 2017 Mar; 81(3):407-418. PubMed ID: 28032667 [TBL] [Abstract][Full Text] [Related]
20. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease. Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]